Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page revision was updated to v3.6.4, signaling an administrative update to the page version. This change does not modify any study details or content presented on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe study page version was updated from v3.6.2 to v3.6.3, signaling a minor revision to the record metadata.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page revision metadata has been updated from v3.6.0 to v3.6.2, indicating a newer version of the study details page.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now shows 'No longer looking for participants', signaling that recruitment has closed. It indicates the study is not accepting new participants.SummaryDifference0.4%

- Check54 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's versioning rather than substantive content changes.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page’s revision label was updated from v3.5.3 to v3.5.4, indicating a new software build. This change does not modify study information or user-facing features beyond the version badge.SummaryDifference0.1%

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.